BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10837790)

  • 1. Site-specific modifications and toxicity of blood substitutes. The case of diaspirin cross-linked hemoglobin.
    D'Agnillo F; Alayash AI
    Adv Drug Deliv Rev; 2000 Feb; 40(3):199-212. PubMed ID: 10837790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymerization of modified diaspirin cross-linked hemoglobin (DCLHb) with 1,6-bismaleimic-hexane.
    Qi D; Wang P; Chen C; Guo S; Wang X
    Artif Cells Nanomed Biotechnol; 2016 Jun; 44(4):1069-74. PubMed ID: 26838092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of polymerization on the hypertensive action of diaspirin cross-linked hemoglobin in rats.
    Abassi Z; Kotob S; Pieruzzi F; Abouassali M; Keiser HR; Fratantoni JC; Alayash AI
    J Lab Clin Med; 1997 Jun; 129(6):603-10. PubMed ID: 9178726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-generation blood substitutes: what have we learned? Biochemical and physiological perspectives.
    Alayash AI; D'Agnillo F; Buehler PW
    Expert Opin Biol Ther; 2007 May; 7(5):665-75. PubMed ID: 17477804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cytotoxic activities of human hemoglobin and diaspirin crosslinked hemoglobin.
    Hsia N; Everse J
    Artif Cells Blood Substit Immobil Biotechnol; 1996 Sep; 24(5):533-51. PubMed ID: 8879427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of polymerization on the oxygen carrying and redox properties of diaspirin cross-linked hemoglobin.
    Rogers MS; Ryan BB; Cashon RE; Alayash AI
    Biochim Biophys Acta; 1995 Apr; 1248(2):135-42. PubMed ID: 7748895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diaspirin crosslinked hemoglobin (DCLHb) polymerization.
    Hai TT; Nelson D; Pereira D; Srnak A
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):923-31. PubMed ID: 7994419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemically modified porcine hemoglobins and their biological properties.
    Jin C; Wen-Fang M; Min H; Pei-Lin C; Zhong-Yi Y
    Protein Pept Lett; 2004 Aug; 11(4):353-60. PubMed ID: 15327368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface modification of diaspirin cross-linked hemoglobin (DCLHb) with chondroitin-4-sulfate derivatives. Part 1.
    Hai TT; Pereira DE; Nelson DJ; Catarello J; Srnak A
    Bioconjug Chem; 2000; 11(5):705-13. PubMed ID: 10995215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diaspirin cross-linked hemoglobin does not increase brain oxygen consumption during hypothermic cardiopulmonary bypass in rabbits.
    Hindman BJ; Dexter F; Cutkomp J; Smith T
    Anesthesiology; 1995 Dec; 83(6):1302-11. PubMed ID: 8533923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of diaspirin cross-linked human hemoglobin solutions.
    Estep TN; Gonder J; Bornstein I; Aono F
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):603-9. PubMed ID: 1391483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential susceptibilities of the prosthetic heme of hemoglobin-based red cell substitutes. Implications in the design of safer agents.
    Osawa Y; Darbyshire JF; Meyer CA; Alayash AI
    Biochem Pharmacol; 1993 Dec; 46(12):2299-305. PubMed ID: 8274164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemoglobin and free radicals: implications for the development of a safe blood substitute.
    Alayash AI; Cashon RE
    Mol Med Today; 1995 Jun; 1(3):122-7. PubMed ID: 9415147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to evaluate blood substitutes for endothelial cell toxicity.
    Gaucher C; Menu P
    Antioxid Redox Signal; 2008 Jul; 10(7):1153-62. PubMed ID: 18331203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diaspirin cross-linked hemoglobin effectively restores pancreatic microcirculatory failure in hemorrhagic shock.
    von Dobschuetz E; Hoffmann T; Messmer K
    Anesthesiology; 1999 Dec; 91(6):1754-62. PubMed ID: 10598619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of effects of two hemoglobin-based O(2) carriers on intestinal integrity and microvascular leakage.
    Baldwin AL; Wiley EB; Alayash AI
    Am J Physiol Heart Circ Physiol; 2002 Oct; 283(4):H1292-301. PubMed ID: 12234778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of sodium selenite in reducing tissue damage caused by three hemoglobin-based oxygen carriers.
    Baldwin AL; Wiley EB; Alayash AI
    J Appl Physiol (1985); 2004 Mar; 96(3):893-903. PubMed ID: 14555684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DBBF modified human placenta hemoglobin through the alpha chains.
    Huang L; Wang B; Wang X; Liang WG; Yang CM
    Artif Cells Blood Substit Immobil Biotechnol; 2008; 36(2):156-65. PubMed ID: 18437592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reaction of human hemoglobin HbA0 and two cross-linked derivatives with hydrogen peroxide: differential behavior of the ferryl intermediate.
    Cashon RE; Alayash AI
    Arch Biochem Biophys; 1995 Jan; 316(1):461-9. PubMed ID: 7840650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redox cycling of diaspirin cross-linked hemoglobin induces G2/M arrest and apoptosis in cultured endothelial cells.
    D'Agnillo F; Alayash AI
    Blood; 2001 Dec; 98(12):3315-23. PubMed ID: 11719369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.